This article is intended for researchers and laboratory professionals. All peptides discussed are for research use only (RUO) and are not approved for human administration, therapeutic use, or clinical application. PeptidesLab UK supplies research-grade Melanotan 2 for in vitro and in vivo laboratory investigations only.
Melanotan 2 in Reproductive Biology: Melanocortin Receptor Signalling and HPG Axis Interactions
Melanotan 2 (MT-II, Ac-Nle⁴-cyclo[Asp⁵-His⁶-D-Phe⁷-Arg⁸-Trp⁹-Lys¹⁰]-OH) is a synthetic cyclic heptapeptide α-MSH analogue incorporating a D-phenylalanine substitution at position 7 and cyclisation via Asp-Lys lactam bridge that confers potent, non-selective agonism at all five melanocortin receptor subtypes (MC1R-MC5R) with particularly high affinity at MC3R and MC4R (Kd values: MC1R ~1 nM, MC3R ~5 nM, MC4R ~0.3 nM, MC5R ~2 nM, measured by competitive [¹²⁵I]-NDP-α-MSH radioligand binding). For reproductive biology research, MC3R and MC4R are the primary relevant subtypes: MC4R is densely expressed in hypothalamic nuclei regulating energy balance and reproductive function (ARC, VMH, PVN, DMH), while MC3R is expressed in the ARC, VTA, and limbic structures with roles in energy sensing and reproduction-energy coupling.
The intersection of melanocortin biology and reproductive function reflects evolutionary conservation of energy status signalling to reproduction: in states of energy deficit (negative energy balance), α-MSH tone falls and AgRP (agouti-related peptide, endogenous MC3R/MC4R inverse agonist) rises, collectively suppressing MC4R-mediated reproductive signalling. This biology underpins the research rationale for Melanotan 2 as a pharmacological probe of energy-reproductive coupling and as a tool for investigating MC3R/MC4R contributions to HPG axis regulation independently of nutritional status.
Hypothalamic MC4R and GnRH Neuron Modulation
MC4R activation in the medial preoptic area (mPOA), anteroventral periventricular nucleus (AVPV), and ARC modulates GnRH neuron activity and LH pulsatility. Research using electrophysiology on acute hypothalamic brain slices (GnRH-GFP transgenic mice, identifying GnRH neurons by fluorescence) demonstrates that α-MSH (100 nM) and Melanotan 2 (10-100 nM) depolarise GnRH neurons and increase firing frequency via MC4R-Gs-cAMP-PKA signalling (confirmed by Rp-cAMPS, a cAMP-PKA antagonist, and MC4R-selective antagonist HS131 or cyclic peptide SHU9119). Whole-cell patch-clamp configuration, -60 mV holding potential, K-gluconate internal solution, 300 mOsm ACSF: action potential frequency before and during 5 min MT-II bath application, washed 10 min, quantified as Hz and represented as peri-stimulus time histograms.
In vivo LH pulse profiling after acute MT-II challenge: serial tail vein sampling (6 min intervals, 3h) with ultra-sensitive LH ELISA (Steyn protocol, detection limit 0.016 IU/L) in freely moving cannulated male and female C57BL/6 mice. MT-II (1 mg/kg i.p.) produces an acute LH surge within 20-40 min in both sexes with return to baseline by 90-120 min — a GnRH-dependent effect confirmed by GnRH-R antagonist cetrorelix (100 μg/kg s.c., 2h before MT-II) abolishing the LH response. Oestrous cycle-staged female studies (proestrus, estrus, metestrus, diestrus by vaginal cytology) demonstrate cycle-dependent MT-II sensitivity: proestrus mice show amplified LH response to MT-II consistent with estrogen-primed MC4R sensitisation.
Kisspeptin-MC4R Interaction: Neuroendocrine Co-signalling
Kisspeptin neurons (ARC KNDy neurons co-expressing kisspeptin-neurokinin B-dynorphin, and AVPV kisspeptin neurons) are direct upstream regulators of GnRH pulse generation and the LH surge. MC4R is expressed on a subset of ARC kisspeptin neurons, creating a direct melanocortin-kisspeptin interface. Research employing dual-label ISH (RNAscope multiplex fluorescent ISH, ACD Bio, simultaneous detection of Kiss1 and Mc4r mRNA in frozen sections, Allen Brain Atlas coordinates ARC -1.5 to -2.5 mm from bregma) establishes the anatomical co-expression substrate. Functional experiments using ARC-selective MT-II microinfusion (200 nL, 100 μM via stereotaxic guide cannula) with kisspeptin antagonist (p234, 10 nmol i.c.v.) administered 30 min before MT-II demonstrates that kisspeptin signalling is required for ARC-specific MT-II’s LH-stimulating effect — positioning Kiss1 neurons as downstream effectors of MC4R-driven LH pulsatility.
NKB (neurokinin B) and dynorphin — the other KNDy components — also intersect with MC4R signalling: dynorphin (κ-opioid, inhibitory) and NKB (NK3R, excitatory) co-modulate pulse generator activity, and MC4R activation shifts the KNDy circuit toward NKB-driven excitation. Senktide (NK3R agonist, 5 nmol i.c.v.) and Melanotan 2 combination versus individual treatment LH pulse profiles determine additive, synergistic, or antagonistic interactions. Nor-BNI (κ-opioid antagonist, 10 mg/kg i.p., 30 min before MT-II) isolates dynorphin-brake effects from the MC4R-stimulated LH response, clarifying the neuroendocrine circuit hierarchy in research designs.
🔗 Related Reading: For a comprehensive overview of Melanotan 2 biology, mechanisms, UK sourcing, and research applications, see our Melanotan 2 Research Guide UK.
Gonadal MC1R and MC5R: Direct Steroidogenic Modulation
Beyond hypothalamic HPG axis modulation, melanocortin receptors expressed directly in gonadal tissues provide a peripheral site of Melanotan 2 action. MC1R is expressed in Leydig cells (RT-PCR and IF, anti-MC1R antibody Santa Cruz sc-393298), granulosa cells, and luteinised theca cells. MC5R is expressed in the corpus luteum of ovaries and in testicular Sertoli cells. These peripheral expression patterns suggest that MT-II’s reproductive effects involve both central (hypothalamic HPG) and peripheral (direct gonadal) components.
Primary Leydig cell research: MC1R-selective agonist BMS-470539 (versus MT-II which activates all MCRs) comparison in testosterone biosynthesis assays (RIA/LC-MS/MS, StAR western, CYP11A1-CYP17A1 qPCR) dissects MC1R-specific from pan-MCR effects. Leydig cell MC1R → Gs-cAMP-PKA-StAR axis parallels the LH-LHCGR-cAMP-StAR pathway, suggesting potential additive steroidogenic effects when both LH and MT-II are present. Competitive inhibition experiments: MT-II + ACTH (4-250 μM, ACTH activates MC2R which is the adrenal-specific ACTH receptor not expressed in Leydig cells, providing a negative specificity control) confirm that any observed Leydig cAMP response is not through MC2R cross-reactivity.
Granulosa cell MC5R research: progesterone production (RIA) in hCG-luteinised primary granulosa cells ± MT-II (1-100 nM); NR5A1 (SF-1, steroidogenic factor 1) mRNA qPCR and CYP11A1 promoter luciferase reporter (containing functional SF-1 binding sites) in JEG-3 trophoblast cells transiently transfected with MC5R expression vector assess MT-II-MC5R-cAMP-PKA-CREB-NR5A1 transcriptional axis. Corpus luteum steroidogenesis is assessed in pseudopregnant (hCG-primed) rat luteal phase, where MT-II systemic injection (1 mg/kg/day s.c., days 2-8 of pseudopregnancy) and progesterone ELISA (plasma, serial) addresses whether MC-driven signalling sustains luteal function.
Female Fertility Research Models: Ovulation, Implantation, and Oestrous Cyclicity
Oestrous cycle regularity as a fertility proxy: female C57BL/6 vaginal cytology (daily, 4-week baseline then 4-week MT-II treatment) scored as proestrus (nucleated epithelial cells), estrus (cornified squamous cells), metestrus (mixed), diestrus (leucocytes) — regular 4-5 day cycles confirm normal HPG axis function. MT-II treatment (0.1-1 mg/kg/day s.c. or i.p.) in energy deficit models (30% caloric restriction × 3 weeks, producing irregular cycles and reduced LH pulsatility) tests whether MC4R activation can restore cyclicity in energy-deficit anovulation — the primary research hypothesis bridging melanocortin and reproduction-energy coupling.
Superovulation response assay (PMSG 5 IU i.p. day 1, hCG 5 IU i.p. 48h later ± MT-II co-treatment, oocyte recovery 14h post-hCG from ampulla of fallopian tube): cumulus-oocyte complex (COC) count, MII oocyte morphology (zona pellucida thickness, polar body extrusion, cytoplasmic granularity by brightfield), and fertilisation rate (in vitro fertilisation with capacitated epididymal sperm, 2-cell embryo rate at 24h in KSOM media) quantify the downstream fertility impact of MC4R-mediated HPG stimulation. Ovarian reserve assessment: AMH ELISA (Ansh Labs) and antral follicle count (AFC, serial vaginal ultrasound using high-frequency probe Vevo 2100, 30 MHz linear transducer) in MT-II-treated versus vehicle aged female mice.
Male Fertility Research: Spermatogenesis, Testosterone, and Sperm Parameters
Male melanocortin-fertility research addresses: (i) testosterone regulation via Leydig cell MC1R and hypothalamic MC4R-LH axis; (ii) direct Sertoli cell MC5R effects on Sertoli-germ cell support; and (iii) sperm parameter effects of chronic MT-II treatment. Adult male Sprague-Dawley rats (8-10 weeks, treatment 4-8 weeks): plasma testosterone by RIA (Coat-A-Count Total Testosterone, Siemens) or LC-MS/MS; LH pulsatility (serial sampling protocol); testicular weight and Leydig cell volume (Weibel point-counting stereology on H&E 5 μm sections); Johnsen score for spermatogenesis; CASA sperm analysis (Hamilton-Thorne IVOS II): concentration, total motility, progressive motility, rapid progressive motility (VSL >45 μm/s), morphology (Diff-Quik normal forms %).
Stress-induced hypogonadotrophic hypogonadism model (CRS, 6h/day × 21 days) produces reduced LH pulse frequency, elevated corticosterone, and reduced testosterone relevant to hypothalamic reproductive suppression. MT-II (0.5 mg/kg/day i.p. during CRS) restoration of LH pulsatility and testosterone assesses MC4R-mediated rescue of stress-induced reproductive suppression. GnRH antagonist cetrorelix (200 μg/kg s.c.) blockade of MT-II-restored LH response confirms pituitary-dependent (hypothalamic GnRH mechanism) versus direct testicular mechanism in the stress model — separating central from peripheral MT-II reproductive biology.
Energy-Reproduction Coupling Research: AgRP, NPY, and MC4R Competition
The reproductive axis is acutely sensitive to energy availability, with AgRP/NPY neurons of the ARC serving as metabolic sensors that gate GnRH pulsatility through MC4R inverse agonism (AgRP) and direct GnRH neuron inhibition (NPY). MT-II as a competitive MC4R agonist reversing AgRP’s reproductive inhibition provides a research tool for mechanistic dissection of energy-reproduction coupling. Selective optogenetic or chemogenetic (DREADDs, Gi-coupled hM4Di) activation of AgRP neurons using Agrp-Cre × ROSA-hM4Di (with CNO 0.3 mg/kg i.p. activation) + MT-II rescue protocol formally establishes whether MC4R agonism is sufficient to overcome AgRP-mediated reproductive suppression.
Fasting (24-48h) reduces hypothalamic α-MSH, elevates AgRP, suppresses LH pulsatility (monitored by serial blood sampling), and increases RFRP-3 (RFamide-related peptide 3, the mammalian homologue of avian GnIH, direct GnRH inhibitor) expression. MT-II administration to 24h-fasted male mice (1 mg/kg i.p.) and LH ELISA at 30 min, 60 min post-injection versus fed controls defines the magnitude of MC4R-driven LH restoration in the energy-deficit context. NPY Y1 receptor blockade (BIBP3226, 0.5 mg/kg i.p.) versus MT-II alone versus combination in fasted mice separates MC4R-axis from NPY-axis contributions to fasting-induced LH suppression.
Control Design and Research Rigour in Reproductive Studies
Rigorous Melanotan 2 reproductive research requires: (i) subtype-selective pharmacological controls — MC4R-selective antagonist HS131 (or SHU9119 which blocks MC3R/MC4R) versus MC1R-selective agonist BMS-470539 versus pan-MCR agonist MT-II, allowing attribution of effects to specific receptor subtypes; (ii) receptor-knockout validation — MC4R-KO (B6;129S4-Mc4r^tm1Lowl/J) and MC3R-KO mice confirm receptor-specific components; (iii) oestrous cycle staging — all female experiments time-locked to cycle phase (vaginal cytology confirmed daily); (iv) sex steroid context — ovariectomised + E2-primed versus intact females, and castrated + T-replaced versus intact males, isolate sex steroid-independent versus -dependent MCR effects on reproduction; (v) NPY/AgRP co-treatment controls — AgRP (83-132) fragment (i.c.v. 0.5 nmol) versus MT-II competition in LH pulse assay; (vi) GnRH-R antagonist verification — cetrorelix pretreatment confirms central HPG mechanism; (vii) diurnal timing — LH studies conducted at fixed zeitgeber times (ZT4 during light phase for tonic LH pulse studies; ZT12 lights-off for LH surge research in female models); (viii) peptide quality — MT-II ≥98% HPLC, MS confirmed cyclic lactam confirmed by MALDI-TOF, endotoxin ≤1 EU/mg.
🇬🇧 UK Research Peptides: PeptidesLab UK supplies COA-verified Melanotan 2 for research and laboratory use. View UK stock →
